financetom
Business
financetom
/
Business
/
Why Tonix Pharmaceuticals Stock (TNXP) Is Getting Obliterated
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Tonix Pharmaceuticals Stock (TNXP) Is Getting Obliterated
Mar 28, 2024 10:34 AM

Tonix Pharmaceuticals Holding Corp ( TNXP ) shares are trading lower by 33.9% to $0.22 Thursday afternoon after the company announced the pricing of a $4.4 million registered direct offering.

Tonix has initiated a securities purchase agreement with existing healthcare-focused institutional investors for the sale of 14,666,666 shares of its common stock and accompanying warrants in a registered direct offering at a combined price of $0.30 per share.

The offering, expected to close around April 1, 2024, is anticipated to generate gross proceeds of approximately $4.4 million. The net proceeds will be allocated towards working capital, general corporate purposes, and partial repayment of debt. A.G.P./Alliance Global Partners is the sole placement agent for the offering.

In addition to the offering, the company has agreed to amend certain existing warrants issued in 2023, reducing their exercise price to $0.33 per share and extending their termination dates.

These amendments are contingent upon shareholder approval, and if not obtained within six months of the offering’s closing, the warrants will have an exercise price equal to the Nasdaq minimum price.

See Also: Elevance, CVS Health Are First Medicare Insurers To Cover Novo Nordisk’s Weight Loss Sensation Wegovy

How To Buy TNXP Stock

By now you're likely curious about how to participate in the market for Tonix Pharmaceuticals ( TNXP ) – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.

In the the case of Tonix Pharmaceuticals ( TNXP ), which is trading at $0.26 as of publishing time, $100 would buy you 384.62 shares of stock.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

According to data from Benzinga Pro, TNXP has a 52-week high of and a 52-week low of

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
China state media says Nvidia must provide 'security proofs' to regain trust
China state media says Nvidia must provide 'security proofs' to regain trust
Aug 1, 2025
BEIJING (Reuters) -Nvidia must produce convincing security proofs to eliminate Chinese users' worries over security risks in its chips and regain market trust, a commentary published China's state-run media People's Daily said on Friday. Foreign companies must comply with Chinese laws and take security to be a basic prerequisite, the commentary said. In a statement sent to Reuters, a Nvidia...
Microsoft in Brazilian antitrust regulator's crosshairs after Opera complaint
Microsoft in Brazilian antitrust regulator's crosshairs after Opera complaint
Aug 1, 2025
BRUSSELS, Aug 1 (Reuters) - Brazil's antitrust enforcer CADE has opened an investigation into Microsoft ( MSFT ), days after Norwegian browser Opera complained about Microsoft's ( MSFT ) Edge, according to a CADE statement published late Thursday on its website. Opera, in its complaint filed on Tuesday, alleged that Microsoft ( MSFT ) pre-installs Edge as the default browser...
Regeneron Pharmaceuticals Q2 Adjusted Earnings, Revenue Rise; Shares Up
Regeneron Pharmaceuticals Q2 Adjusted Earnings, Revenue Rise; Shares Up
Aug 1, 2025
06:53 AM EDT, 08/01/2025 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) reported Q2 adjusted earnings Friday of $12.89 per diluted share, up from $11.56 a year earlier. Analysts surveyed by FactSet expected $8.43. Revenue for the quarter ended June 30 was $3.68 billion, compared with $3.55 billion a year earlier. Analysts polled by FactSet expected $3.29 billion. ...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved